Skip to content

Dibenzepin

NERVOUS SYSTEM

Also known as: dibenzepin HCl, dibenzepin hydrochloride, dibenzepine, dibenzepine HCl, dibenzepine hydrochloride

ATC N06AA08

Data last refreshed: (DrugCentral release 2024-11-01)

Key facts

Dibenzepin is a drug catalogued in DrugCentral. DrugCentral lists 7 molecular targets, including HRH1, HTR1A and HTR6.

  • Molecular targets: HRH1, HTR1A, HTR6 and HTR2A (7 listed in DrugCentral).
  • ATC code: N06AA08 (Non-selective monoamine reuptake inhibitors).
  • Molecular formula: C18H21N3O; molecular weight 295.39 g/mol.

Mechanism & targets

Molecular targets (7)

TargetGeneActionActivity
Histamine H1 receptorHRH1unknownKi 7.70
5-hydroxytryptamine receptor 1AHTR1AunknownKi 5.60
5-hydroxytryptamine receptor 6HTR6unknownKi 5.48
5-hydroxytryptamine receptor 2AHTR2AunknownKi 5.14
Sodium-dependent serotonin transporterSLC6A4unknownKi 4.96
5-hydroxytryptamine receptor 7HTR7unknownKi 4.91
D(2) dopamine receptorDRD2unknownKi 4.52

ATC classification

ATC codeTherapeutic hierarchy
N06AA08NERVOUS SYSTEM › PSYCHOANALEPTICS › ANTIDEPRESSANTS › Non-selective monoamine reuptake inhibitors

Chemical structure

Full physicochemical, ADMET and 3D-structure analysis of Dibenzepin is on its molecule page.

Molecular formulaC18H21N3O
Molecular weight295.39 g/mol
CAS number4498-32-2
InChIKeyQPGGEKPRGVJKQB-UHFFFAOYSA-N
PubChem CID9419
CN(C)CCN1C2=C(C=CC=C2)N(C)C2=CC=CC=C2C1=O

Frequently asked questions

Answers are generated from the structured data on this page, not written by hand.

How does Dibenzepin work?

Its molecular targets in DrugCentral include HRH1, HTR1A, HTR6 and HTR2A.

What is the chemical formula of Dibenzepin?

Dibenzepin has the molecular formula C18H21N3O and a molecular weight of 295.39 g/mol.

Browse: all drugs starting with D · drug guides by category · protein targets A–Z.

Sources

How this page is built: methodology · editorial policy & corrections.

For research and educational use only — not medical advice. This page is compiled automatically from public databases. It is not written or reviewed by a clinician. Do not start, stop or change any treatment based on it; consult a qualified healthcare professional. Spotted an error? See our corrections policy or email hello@molforge.ai.

Quick facts

Status—
First approval—
Agency—
Targets7
Indications0
FormulaC18H21N3O
DrugCentral ID856
Interactive profile